Fortress Biotech reports fourth quarter and full-year 2017 financial results
Fortress Biotech reported the net loss was $66.9 million, or $1.61 per share, for the 2017 year end versus a net loss of $55.1 million, or $1.38 per share, for 2016. Net revenue totaled $187.6 million for the full year 2017, compared to $16.5 million in 2016. March 16, 2018